Wednesday, June 25, 2014

No down payment medical, dental and healthcare provider practice financing here! + More News: FDA panel recommends more clinical data on AstraZeneca drug + MORE 06/26/2014

Doctor Practice Financing – Click Here for 100 percent financing for doctors starting up a practice or acquiring one!


Call: 904-551-6090


As you decide to start this important personal process, you will be required to create a detailed business plan that will include all the required elements for the medical practice. This formulated business plan will be of use to us so that we can be able to assess your general operation. You will be pleased to know that as lenders we are dedicated to undertake a fair assessment process of your plan so that we can effectively provide for the required finances that will be sufficient to handle all the initial company processes. With the cash-flow project that will be reflected by your business plan, you will be set to obtain a reasonable amount to money for your medical practice.


Read The Interesting Snippets Below For Exciting Health-Care News!





* Dow up 0.3 pct; S&P 500 up 0.5 pct; Nasdaq up 0.7 pct (Updates to close)

Continue Reading On http://www.reuters.com »




WASHINGTON, June 25 (Reuters) – Two senior Republican lawmakers voiced support on Wednesday for the generic drug industry’s fight against a proposed U.S. rule requiring companies to change labels on products if they receive new safety information.

Continue Reading On http://www.reuters.com »




Platelet injections don’t speed hamstring repair: study


– http://www.reuters.com/healthNews


NEW YORK (Reuters Health) – Injecting platelets from the blood into a damaged hamstring muscle does nothing to speed healing, according to a new study of a technique that is becoming increasingly popular with doctors despite a lack of hard evidence that it works.

Continue Reading On http://www.reuters.com/healthNews »




WASHINGTON (Reuters) – An advisory panel to the U.S. Food and Drug Administration recommended on Wednesday that AstraZeneca Plc be required to submit further clinical data before its experimental ovarian cancer drug is approved.

Continue Reading On http://www.reuters.com/healthNews »




(Reuters) – A consumer advocacy group on Wednesday asked the U.S. Food and Drug Administration to add a safety warning on energy drinks because the caffeine-charged beverages have been linked to 17 deaths since October 2012.

Continue Reading On http://www.reuters.com/healthNews »




NEW YORK (Reuters Health) – Obstetricians recognize that exposure to chemicals and metals can affect a pregnancy, but said in a new survey that they face barriers to counseling patients about environmental hazards.

Continue Reading On http://www.reuters.com/healthNews »




No down payment medical, dental and healthcare provider practice financing here! + More News: FDA panel recommends more clinical data on AstraZeneca drug + MORE 06/26/2014

No comments: